These experiments suggest that raised levels of autoantibodies to certain cytoskeletal and nuclear determinants may be a feature of oesophageal cancer.
An autoimmune response occurs when the immune system is exposed to antigens normally found within the cell. It is a common phenomenon in diseased patients, as well as normal healthy individuals (Christian & Elkon, 1986; Serre et al., 1987; Iwatsuki et al., 1986; Passaleva et al., 1986) . Autoantibodies against intracellular antigens can be broadly subdivided into two groups, (a) nuclear and (b) cytoplasmic. The nuclear group comprises autoantibodies to DNA, histones, non-histone proteins and nucleolar antigens. These antibodies could be described as having a loose association with rheumatic and blood diseases (Passaleva et al., 1986; Christian & Elkon, 1986) . On the other hand, the cytoplasmic group is primarily represented by autoantibodies against constituents of the three cytoskeletal systems: the microfilaments, microtubules and the intermediate filaments (Alcover et al., 1985; Senecal et al., 1985; Zauli et al., 1985) . Circulating antibodies to the microfilaments and microtubules, or actin and tubulin respectively, have been demonstrated in patients with a variety of liver diseases, rheumatoid diseases, SLE and in some other less common syndromes (Kurki et al., 1983a, b; Senecal et al., 1985; Zauli et al., 1985) .
As the cytokeratins comprise the largest subfamily within the intermediate group of filaments (containing some 20 distinct polypeptides), it is not surprising that autoantibodies to cytokeratins occur in human sera Serre et al., 1987) . In fact, autoantibodies to epidermal cytokeratins seem to be a common phenomenon in human sera. Studies have shown that most, though not all, human antiepidermal antibodies are directed against cytokeratin polypeptides characteristic of the basal, suprabasal and stratum corneum cell layers (Abel & Bystryn, 1976; Paluch & Bloch, 1982; Hintner et al., 1983; Iwatsuki et al., 1986) .
The synthesis of antibodies to cytokeratins specific to basal or suprabasal epidermal strata appears to be a characteristic of certain epidermal diseases, such as bullous pemphigus (see Viac et al., 1986 keratins in human serum are associated with the presence of squamous cell carcinoma (SCC).
At present, little or nothing is known about the specificity of circulating autoantibodies to antigenic components of stratified squamous epithelia other than the epidermis, for example, the cytokeratins of the internal organs such as the oesophagus. It should be noted that the oesophageal epithelium expresses its own distinctive subset of acidic and basic cytokeratin polypeptides (Moll et al., 1982) , a pattern which is maintained in the associated neoplasms (Moll et al., 1982; Grace et al., 1985) .
Oesophageal SCC has a global distribution but epidemiological studies indicate that, geographically, Africa and in particular South Africa, has the highest incidence (Rose, 1973; Day, 1975; Harington & Bradshaw, 1978) .
Lack of a method for early detection has made treatment extremely difficult. Palliation is the only form of management possible in the vast majority of patients (Mannell, 1982) (Bey et al., 1976) or D98 HeLa cells (courtesy of E.J. Stanbridge, University of California, Irvine) both of which were grown in vitro. All of the above extracts were produced according to the method of Franke et al. (1981) . Briefly, confluent cell cultures or epithelial scrapes received a rinse with phosphate buffered saline (PBS) followed by a rinse with TNE buffer (140mM NaCl, 1 mM EDTA, 10mM Tris-HCl pH 7.6) containing 1 mM phenyl-methyl-sulphonyl-fluoride (PMSF) and Trasylol (100 kallikrein units/ml). Cultured cells were then scraped off the substrate, collected in TNE buffer and pelleted. The cellular or epithelial pellet was subjected to a two step extraction procedure. Firstly, resuspension in TNE buffer containing 1% Triton X-100 for 5min, a TNE wash, followed by a second extraction of the pellet in TNE containing 1.5 M KCl and 0.5% Triton X-100 for a period of 20 min. After a further two washes with TNE buffer, the final sediment was taken up in lysis buffer (Laemmli, 1970) ; and boiled for 5 min. The extracted cytokeratin proteins were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in a 12.5% vertical slab gel (Laemmli, 1970) .
Radioimmunoassay
All radioimmunoassay experiments were performed in triplicate. Nitrocellulose paper discs, 5 mm in diameter (Sartorious SM 114), were soaked for 2 h in a 1 mg ml -solution of cytoskeletal extract (see above). Protein determination performed on the discs after the 2 h soak showed that the discs consistently adsorbed 5 jug protein. Any remaining background was masked by a 2 h treatment with 'blotto' (5% low-fat dried milk, 0.05% Triton X-100, 0.01% Antifoam A in 50mM Tris-HCI pH 7.8 (see Hauri & Bucher, 1986 ) and the discs then incubated in 1: 10 dilution of human serum for 1 h. This serum dilution was determined by incubating the discs containing 5 pg of protein in serially diluted sera in order to identify the saturation level. Serum titre producing maximal binding in 8 randomly chosen sera ranged between dilutions of 1:250 and 1:10. As a result all tests were conducted at the 1:10 dilution. After four washes in blotto (15 min per wash) the discs were incubated in 20 ml of blotto containing 2 !LCi 125I-protein A (Amersham) for 1 h. Finally the discs were again washed in blotto as above, rinsed in PBS, air dried and counted in a Packard Autogamma counter.
Immunoblotting Cytokeratin extracts produced as above were separated by 12.5% SDS-PAGE and transferred to nitrocellulose paper at 4°C for 2 h (Towbin et al., 1979) , and the background blocked in blotto as above. The nitrocellulose paper was then divided into 1 cm wide strips and each strip incubated in 1:50 serum in blotto over night. Strips were washed in 4 changes of blotto over 2 h before being incubated in 12511
Protein A for 2 h (1,Ci/l0 ml in hlotto). Finally the strips were again washed in blotto as above, air dried and autoradiographed on Fuji X-ray plate.
Immunofluorescence
Immunofluorescence procedures were performed essentially as described by Sun and Green (1978) and Franke et al. (1978) using human serum diluted at 1:10. Antibody/antigen complexes were visualised by a two-step method of first reacting with biotinylated goat anti-human IgG (1:250) followed thereafter by binding FITC-conjugated streptavidin (1:200).
Results
Radioimmunoassay experiments (RIA) Figure 1 shows that the normal oesophageal epithelium expresses 8 cytokeratin polypeptides; four high MW components and four subunits with lower mol. wts (la track 2, and lb). Although autoantibodies to oesophageal cytokeratins were present in the serum from normal healthy subjects and patients with oesophageal SCC, there was no significant difference in antibody titre between the groups when the oesophageal cytokeratins were employed as the bound antigen ( Figure 2) .
A clear, statistically significant (P<0.001) difference in autoantibody titre between healthy subjects, and patients with oesophageal SCC was observed in experiments using SNO cell extracts (containing cytokeratins (5), 8, 18 and 19 see Figure 3) .
Sera from 14 patients with histologically confirmed mild active oesophagitis were compared with sera from normal subjects, and patients with oesophageal SCC. As can be seen from Figure 3 , patients with mild active oesophagitis were no different to healthy subjects with respect to autoantibody titre against SNO extracts.
In order to establish that the increase in autoantibody titre was not perhaps against trace amounts of proteins specific to SNO cells, serum analyses were repeated using extracts from HeLa cells, which express cytokeratin components 8, 18 and vimentin (see Figure la track 4 and Id also Moll et al., 1982) . Almost identical values (see Figure 3 ) were obtained; a significant increase in autoantibody titre was seen to occur in the sera from patients with confirmed oesophageal SCC. This result suggests that the presence of cytokeratins (5), 19 and several distinctive cytoskeletal-associated proteins, which are present in the SNO, but not in the HeLa extracts, played no role in the determination of antibody titre. Likewise, vimentin can be excluded as an autoantigen as it is a major component of the cytoskeleton in HeLa cells but not in the SNO cells. This observation makes clear the distinction, on the basis of autoantibody titre, between SCC and diseases like SLE where the primary autoantigen is vimentin (Alcover et al., 1985) .
Immunofluorescence studies The cytokeratin cytoskeletal specificity of the circulating autoantibodies was confirmed for 62 sera by immunofluorescence analyses. Out of the 62 sera only 7 from controls and 11 from patients with oesophageal carcinoma displayed a relatively strong positive staining reaction on normal human oesophageal epithelial cells grown in tissue culture. The fibrous pattern indicative of anticytoskeletal antibodies or a prominent nucleolar staining was observed in these cases (see Figure 4) .
Both the number of reactive sera, and the intensity of the staining were increased when the same range of sera were tested on SNO cells. That is, 10 sera from the normal controls produced strongly positive results and similarly, 21 sera from patients with carcinoma of the oesophagus. (v) . The arrow indicates actin. The pH gradient is indicated across the top of the figure (Gel= 12.5%).
filamentous nature although there was also evidence of granular cytoplasmic, nuclear membrane and nucleolar staining (see Figure 4) . The characteristic staining patterns of actin and vimentin, which are easily distinguished from the cytokeratin-type, were never observed. A typical actin or vimentin fibrous network was absent when immunofluorescence was performed on D98 HeLa, cells which synthesize comparatively large amounts of vimentin (see Figure ld) .
Western blotting analyses Samples of the same SNO extracts, separated by SDS-PAGE and transferred to nitrocellulose, were used to determine the specificity of the autoantibodies present in a range of sera.
Of the 28 sera employed in the blotting experiments 10 examples of the various reactions obtained are shown in Figure 5 . All the sera contained autoantibodies which reacted with cytokeratin 18, and seventy percent with both 8 and 18. Sixty percent of the sera tested contained autoantibodies to a third component in addition to the above two, viz., cytokeratin 19. Fairly uncommon was the presence of an antibody to a fourth polypeptide (58 kD mol. wt., possibly cytokeratin 5 which occurs in trace amounts in SNO extracts) which reacted strongly when present. A few of the sera contained antibodies to an additional high mol. wt. component (HMW in Figure 5 ). This is probably not a cytokeratin since it reacted neither with AEI nor AE3 monoclonal antibodies to cytokeratin (kindly provided by T.-T. Sun, Department of Dermatology, New York University).
Discussion
There is only one prior report quantifying serum antikeratin activity in patients with SCC. geal epithelium are present in the serum of normal subjects and patients with SCC of the oesophagus. Using a solid phase radioimmunoassay, and the set of normal oesophageal cytokeratins (polypeptides nos. 4, 5, 6, 13, 14/15, 16 and 19) as the bound antigen, we found no significant difference in autoantibody titre (Figure 2 ). (1985) have shown some time ago that SLE is linked to a raised autoantivimentin titre. Several authors have postulated that mild active oesophagitis precedes the onset of oesophageal SCC (Mannell, 1982) . The data presented in Figure 3 show that there is no difference in the titre of autoantibodies to components of the simple cytoskeleton when normal, healthy controls, and patients with histologically confirmed mild active oesophagitis were compared. These observations lead one to conclude that either mild active oesophagitis may be a condition unconnected with oesophageal SCC, or that there is an intermediate step which hitherto has escaped detection. It is important to note that patients with moderate oesophagitis, which one has been led to suspect as the next step in the progression towards SCC (see Mannell, 1982) are normally very rarely detected. We were able to test only one such case in this study (1/14=7.1%) the result of which was indistinguishable from the mild cases. Similarly, adenocarcinoma of the oesophagus forms less than five percent of the cases presenting at Baragwanath Hospital. Our data are as yet insufficient to say whether adenocarcinoma and SCC can be distinguished on the basis of this radioimmunoassay. To date there is no reliable technique that distinguishes between mild active oesophagitis and the preneoplastic state, or stages thereof, as in cancer of the cervix (Raebin, 1983) . Clearly every avenue should be thoroughly explored which could possibly facilitate a more accurate early diagnosis of the disease.
Western blotting experiments performed using the sera from the patients with oesophageal SCC showed that, although antibodies to each of the simple epithelial cytokeratins were present in one or another serum, antibodies to polypeptide 18 were present throughout (see Figure 5 ). This is the first report showing an increased autoantibody titre to a particular cytokeratin in patients with SCC. Future studies will show whether autoantibodies to cytokeratin 18 are associated only with oesophageal SCC or with a variety of unrelated disorders, and perhaps provide an explanation as to why cytokeratin 18 is more antigenic than other similar proteins.
In addition to the identifiable cytokeratin polypeptides, there was at least one other immunoreactive non-cytokeratin protein (A. Thornley, unpublished results) present in the high-salt cytoskeletal residue (see HMW in Figure 5 ). The identity of these proteins is at present unknown but it has been shown that cytoskeletal-associated proteins frequently co-purify with intermediate filaments (Lieska et al., 1985) .
Autoantibodies to cytoskeletal components such as actin, vimentin, desmin and cytokeratin have been described in diseases such as SLE, rheumatoid arthritis, liver diseases and bullous diseases (Kurki et al., 1983a,b; Ordeig & Guardia, 1984; Senecal et al., 1985; Alcover et al., 1985; Hajiroussou et al., 1985) . Patients with oesophageal SCC may have raised levels of autoantibodies to nuclear as well as cytoskeletal structures. Nuclear, nuclear membrane and in particular nucleolar staining were striking features of many of the sera tested on cultures of normal oesophageal epithelial cells or SNO cells (Figure 4) .
Several authors subscribe to the idea that anticytokeratin antibodies are formed in response to epithelial cell injury or death (Kurki & Virtanen, 1984; Zauli et al., 1985; Grubauer et al., 1986; Hintner et al., 1987) . A similar event could account for our results. The most difficult observation to explain is why antibodies should form predominantly to the simple epithelial cytokeratins, and to number 18 in particular. Previously we reported atypical cytokeratin expression in vitro by a human oesophageal SCC cell line (Veale & Thornley, 1984) . This involved the synthesis of a cytokeratin profile which was distinctly simple epithelial-like in nature consisting of polypeptides 8, 18 and 19 with trace amounts of 5 also present (see Figure la track 3 and 1c, confirmed using antibodies AEI and AE3, Thornley unpublished results). Terry et al. (1986) have now reported the presence of simple cytokeratins in primary oesophageal tumours, but this is not true for SCCs in general (Moll et al., 1983; Rheinwald et al., 1984) or oesophageal SCCs in particular (Grace et al., 1985; Van Muijen et al., 1986 (Weber et al., 1984) . However, other likely candidates cannot be ignored, such as the surrounding mesothelium, which characteristically expresses simple type cytokeratins, or even viral epitopes which are sufficiently similar to illicit autoimmune responses through molecular mimicry (Oldstone, 1987) .
